These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 26936786)

  • 21. GPR109A (PUMA-G/HM74A) mediates nicotinic acid-induced flushing.
    Benyó Z; Gille A; Kero J; Csiky M; Suchánková MC; Nüsing RM; Moers A; Pfeffer K; Offermanns S
    J Clin Invest; 2005 Dec; 115(12):3634-40. PubMed ID: 16322797
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Upregulation of GPR109A in Parkinson's disease.
    Wakade C; Chong R; Bradley E; Thomas B; Morgan J
    PLoS One; 2014; 9(10):e109818. PubMed ID: 25329911
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Niacin activates the G protein estrogen receptor (GPER)-mediated signalling.
    Santolla MF; De Francesco EM; Lappano R; Rosano C; Abonante S; Maggiolini M
    Cell Signal; 2014 Jul; 26(7):1466-75. PubMed ID: 24662263
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The β-hydroxybutyrate receptor HCA2 activates a neuroprotective subset of macrophages.
    Rahman M; Muhammad S; Khan MA; Chen H; Ridder DA; Müller-Fielitz H; Pokorná B; Vollbrandt T; Stölting I; Nadrowitz R; Okun JG; Offermanns S; Schwaninger M
    Nat Commun; 2014 May; 5():3944. PubMed ID: 24845831
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The niacin/butyrate receptor GPR109A suppresses mammary tumorigenesis by inhibiting cell survival.
    Elangovan S; Pathania R; Ramachandran S; Ananth S; Padia RN; Lan L; Singh N; Martin PM; Hawthorn L; Prasad PD; Ganapathy V; Thangaraju M
    Cancer Res; 2014 Feb; 74(4):1166-78. PubMed ID: 24371223
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gut microbial metabolite butyrate protects against proteinuric kidney disease through epigenetic- and GPR109a-mediated mechanisms.
    Felizardo RJF; de Almeida DC; Pereira RL; Watanabe IKM; Doimo NTS; Ribeiro WR; Cenedeze MA; Hiyane MI; Amano MT; Braga TT; Ferreira CM; Parmigiani RB; Andrade-Oliveira V; Volpini RA; Vinolo MAR; Mariño E; Robert R; Mackay CR; Camara NOS
    FASEB J; 2019 Nov; 33(11):11894-11908. PubMed ID: 31366236
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nicotinic acid: recent developments.
    Kamanna VS; Vo A; Kashyap ML
    Curr Opin Cardiol; 2008 Jul; 23(4):393-8. PubMed ID: 18520725
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nicotinic acid- and monomethyl fumarate-induced flushing involves GPR109A expressed by keratinocytes and COX-2-dependent prostanoid formation in mice.
    Hanson J; Gille A; Zwykiel S; Lukasova M; Clausen BE; Ahmed K; Tunaru S; Wirth A; Offermanns S
    J Clin Invest; 2010 Aug; 120(8):2910-9. PubMed ID: 20664170
    [TBL] [Abstract][Full Text] [Related]  

  • 29. GPR109A alleviate mastitis and enhances the blood milk barrier by activating AMPK/Nrf2 and autophagy.
    Guo W; Li W; Su Y; Liu S; Kan X; Ran X; Cao Y; Fu S; Liu J
    Int J Biol Sci; 2021; 17(15):4271-4284. PubMed ID: 34803497
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel 3,6,7-substituted pyrazolopyrimidines as positive allosteric modulators for the hydroxycarboxylic acid receptor 2 (GPR109A).
    Blad CC; van Veldhoven JP; Klopman C; Wolfram DR; Brussee J; Lane JR; Ijzerman AP
    J Med Chem; 2012 Apr; 55(7):3563-7. PubMed ID: 22420767
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selective hepatic vagotomy eliminates the hypophagic effect of different metabolites.
    Langhans W; Egli G; Scharrer E
    J Auton Nerv Syst; 1985 Jul; 13(3):255-62. PubMed ID: 4031363
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High dietary niacin may increase prostaglandin formation but does not increase tumor formation in ApcMin/+ mice.
    Kwong AM; Tippin BL; Materi AM; Buslon VS; French SW; Lin HJ
    Nutr Cancer; 2011; 63(6):950-9. PubMed ID: 21774590
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Niacin inhibits skin dendritic cell mobilization in a GPR109A independent manner but has no impact on monocyte trafficking in atherosclerosis.
    Ingersoll MA; Potteaux S; Alvarez D; Hutchison SB; van Rooijen N; Randolph GJ
    Immunobiology; 2012 May; 217(5):548-57. PubMed ID: 21798616
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nicotinic acid (niacin) receptor agonists: will they be useful therapeutic agents?
    Kamanna VS; Kashyap ML
    Am J Cardiol; 2007 Dec; 100(11 A):S53-61. PubMed ID: 18047854
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Deficiency of metabolite sensing receptor HCA2 impairs the salutary effect of niacin in hemorrhagic shock.
    Subramani K; Chu X; Warren M; Lee M; Lu S; Singh N; Raju R
    Biochim Biophys Acta Mol Basis Dis; 2019 Mar; 1865(3):688-695. PubMed ID: 30625381
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Colonic gene expression in conventional and germ-free mice with a focus on the butyrate receptor GPR109A and the butyrate transporter SLC5A8.
    Cresci GA; Thangaraju M; Mellinger JD; Liu K; Ganapathy V
    J Gastrointest Surg; 2010 Mar; 14(3):449-61. PubMed ID: 20033346
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discovery of 4-(phenyl)thio-1H-pyrazole derivatives as agonists of GPR109A, a high affinity niacin receptor.
    Kim HY; Jadhav VB; Jeong DY; Park WK; Song JH; Lee S; Cho H
    Arch Pharm Res; 2015 Jun; 38(6):1019-32. PubMed ID: 25599616
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analogues of acifran: agonists of the high and low affinity niacin receptors, GPR109a and GPR109b.
    Jung JK; Johnson BR; Duong T; Decaire M; Uy J; Gharbaoui T; Boatman PD; Sage CR; Chen R; Richman JG; Connolly DT; Semple G
    J Med Chem; 2007 Apr; 50(7):1445-8. PubMed ID: 17358052
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Future of GPR109A agonists in the treatment of dyslipidaemia.
    Wanders D; Judd RL
    Diabetes Obes Metab; 2011 Aug; 13(8):685-91. PubMed ID: 21418500
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discovery of orally bioavailable and novel urea agonists of the high affinity niacin receptor GPR109A.
    Shen HC; Szymonifka MJ; Kharbanda D; Deng Q; Carballo-Jane E; Wu KK; Wu TJ; Cheng K; Ren N; Cai TQ; Taggart AK; Wang J; Tong X; Waters MG; Hammond ML; Tata JR; Colletti SL
    Bioorg Med Chem Lett; 2007 Dec; 17(24):6723-8. PubMed ID: 18029181
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.